Intercept Pharma Danmark ApS

CVR 37104469 · Private limited company (ApS) · Dissolved by declaration

Intercept Pharma Danmark ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. The company is no longer active (status: dissolved by declaration). 4 annual reports have been published. The latest annual report (31 Dec 2019) shows equity of DKK -38.9m and a net result of DKK -27k.

Company details

CVR number
37104469
Status
Dissolved by declaration
Company type
Private limited company (ApS)
Founded
Ceased
Address
c/o Harbour House, Sundkrogsgade 21
2100 København Ø
Municipality
København
Industry
Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr
Share capital
DKK 50k
Employees
1 (2018)
Auditor
Mazars
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 4
Missing annual reportNo
Negative equityYes
Equity ratio-400.1%
Current ratio20%
Moves (last 2 years)1
CEO changes in total6
CEO's previous bankruptcies0
Other companies at the address472
Going-concern uncertaintyNo

Financials and key figures

Financial year20192018
Gross profitDKK 2.8mDKK 1.0m
Net profitDKK -27kDKK -7.1m
EquityDKK -38.9mDKK -38.9m
Total assetsDKK 9.7mDKK 8.4m
CashDKK 39k–
Short-term debtDKK 48.6m–
Tax owedDKK 66k–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Mazars.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2019 – 31 Dec 2019122
1 Jan 2018 – 31 Dec 2018151
1 Jan 2017 – 31 Dec 2017150
23 Sep 2015 – 31 Dec 2016153

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOSeokho Bryan Yoon
CEOBarbara Duncan
CEOGülizar Aybasti Skjoldager
CEOSandipkumar Shantilal Kapadia
CEODaniel Hood
Owner (100%)Intercept Pharmaceuticals Inc.
FounderPeter Andreas Nielsen

The CEOs' other companies

Gülizar Aybasti Skjoldager – 2 other companies

Address history (2 moves)

c/o Harbour House, Sundkrogsgade 21, 2100 København Ø
Lyngby Hovedgade 10C, 2800 Kgs. Lyngby
c/o Bruun & Hjejle, Nørregade 21, 1165 København K

Employees per year

Number of employees at Intercept Pharma Danmark ApS per year352016: 520162017: 520172018: 12018

Other companies at the same address

Similar companies in København

Questions and answers about Intercept Pharma Danmark ApS

Has Intercept Pharma Danmark ApS gone bankrupt?

No, Intercept Pharma Danmark ApS is not registered as bankrupt in the CVR register. Its status is: dissolved by declaration.

Who is the auditor of Intercept Pharma Danmark ApS?

Intercept Pharma Danmark ApS most recently used Mazars.

When was Intercept Pharma Danmark ApS founded?

Intercept Pharma Danmark ApS was founded on 23 September 2015.

What is the equity of Intercept Pharma Danmark ApS?

Equity was DKK -38.9m according to the annual report for the period ending 31 December 2019.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.